2-propan-2-yl-5-(5-propan-2-yl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-yl)-7-oxabicyclo[4.1.0]hepta-1,3,5-triene
C18H18O2 — CID 175725025
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-propan-2-yl-5-(5-propan-2-yl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-yl)-7-oxabicyclo[4.1.0]hepta-1,3,5-triene
2-propan-2-yl-5-(5-propan-2-yl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-yl)-7-oxabicyclo[4.1.0]hepta-1,3,5-triene (PubChem CID 175725025) has the molecular formula C18H18O2 and a molecular weight of 266.34 g/mol. Its IUPAC name is 2-propan-2-yl-5-(5-propan-2-yl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-yl)-7-oxabicyclo[4.1.0]hepta-1,3,5-triene.
Molecular Properties
| Compound Name | 2-propan-2-yl-5-(5-propan-2-yl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-yl)-7-oxabicyclo[4.1.0]hepta-1,3,5-triene |
|---|---|
| PubChem CID | 175725025 |
| Molecular Formula | C18H18O2 |
| Molecular Weight | 266.34 g/mol |
| Exact Mass | 266.13 |
| IUPAC Name | 2-propan-2-yl-5-(5-propan-2-yl-7-oxabicyclo[4.1.0]hepta-1,3,5-trien-2-yl)-7-oxabicyclo[4.1.0]hepta-1,3,5-triene |
| SMILES | CC(C)c1ccc(-c2ccc(C(C)C)c3c2O3)c2c1O2 |
| InChI | InChI=1S/C18H18O2/c1-9(2)11-5-7-13(17-15(11)19-17)14-8-6-12(10(3)4)16-18(14)20-16/h5-10H,1-4H3 |
| InChIKey | ZGKKNNUYUOPAEY-UHFFFAOYSA-N |
| XLogP | 5.81 |
| TPSA | 25.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 266.34 |
| LogP ≤ 5 | 5.81 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175725025 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.